PEOPLE - Changes at Centocor (US):
This article was originally published in Clinica
US company Centocor has made the following organizational changes: Joseph Scodari has been promoted to president and chief operating officer, succeeding David Holveck who continues as CEO; the company's CFO, Dominic Caruso, becomes a senior vice-president; and Dr Christopher Hentschel joins the company as senior vice-president and chief scientific officer from the UK's Medical Research Council Collaborative Centre.
You may also be interested in...
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.